Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities from Discontinued Operations (2017 - 2023)

Lifecore Biomedical, Inc. \De\ has reported Liabilities from Discontinued Operations over the past 6 years, most recently at 518000.0 for Q1 2023.

  • Quarterly results put Liabilities from Discontinued Operations at 518000.0 for Q1 2023, down 94.11% from a year ago — trailing twelve months through Feb 2023 was 518000.0 (down 94.11% YoY), and the annual figure for FY2022 was 2325000.0, down 95.3%.
  • Liabilities from Discontinued Operations for Q1 2023 was 518000.0 at Lifecore Biomedical, Inc. \De\, down from 16832000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for LFCR hit a ceiling of 66454000.0 in Q4 2020 and a floor of 518000.0 in Q1 2023.
  • Median Liabilities from Discontinued Operations over the past 4 years was 16832000.0 (2022), compared with a mean of 29676000.0.
  • Peak annual rise in Liabilities from Discontinued Operations hit 21.41% in 2022, while the deepest fall reached 95.8% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Liabilities from Discontinued Operations stood at 66454000.0 in 2020, then decreased by 6.08% to 62416000.0 in 2021, then tumbled by 73.03% to 16832000.0 in 2022, then plummeted by 96.92% to 518000.0 in 2023.
  • The last three reported values for Liabilities from Discontinued Operations were 518000.0 (Q1 2023), 16832000.0 (Q4 2022), and 2153000.0 (Q3 2022) per Business Quant data.